Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection
Viruses · 2024
DOI: 10.3390/v16081317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Priyanka Saha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700010, India. Hauptthemen laut MEDLINE: Minocycline, Antiviral Agents, Virus Replication, Active Transport, Cell Nucleus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Influenza A virus (IAV) poses a global threat worldwide causing pandemics, epidemics, and seasonal outbreaks. Annual modification of vaccines is costly due to continual shifts in circulating genotypes, leading to inadequate coverage in low- and middle-income countries like India. Additionally, IAVs are evolving resistance to approved antivirals, necessitating a search for alternative treatments. In this study, the antiviral role of the FDA-approved antibiotic minocycline against IAV strains was evaluated in vitro and in vivo by quantifying viral gene expression by qRT-PCR, viral protein levels by Western blotting, and viral titers. Our findings demonstrate that minocycline at a non-toxic dose effectively inhibits IAV replication, regardless of viral strain or cell line. Its antiviral mechanism operates independently of interferon signaling by targeting the MEK/ERK signaling pathway, which is crucial for the export of viral ribonucleoproteins (vRNPs). Minocycline prevents the assembly and release of infectious viral particles by causing the accumulation of vRNPs within the nucleus. Moreover, minocycline also inhibits IAV-induced late-stage apoptosis, further suppressing viral propagation. The antiviral activity of minocycline against IAVs could offer a promising solution amidst the challenges posed by influenza and the limitations of current treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Virology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700010, India.
- Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases, Kolkata 700010, India.
Zitieren
APA
Saha, P., Saha, R., Datta Chaudhuri, R., Sarkar, R., Sarkar, M., Koley, H., & Chawla-Sarkar, M. (2024). Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection. Viruses. https://doi.org/10.3390/v16081317
Vancouver
Saha P, Saha R, Datta Chaudhuri R, Sarkar R, Sarkar M, Koley H, et al. Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection. Viruses. 2024. doi:10.3390/v16081317
BibTeX
@article{Saha2024,
author = {Saha, Priyanka and Saha, Ritubrita and Datta Chaudhuri, Ratul and Sarkar, Rakesh and Sarkar, Mehuli and Koley, Hemanta and Chawla-Sarkar, Mamta},
title = {Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16081317}
}
EUVIMED